The report 'Orexin Receptor Type 1 Pipeline Review, H2 2017' outlays comprehensive information on the Orexin Receptor Type 1 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type; that are being developed by Companies / Universities.
Orexin Receptor Type 1 Orexin receptor type 1 (Ox1R or OX1) is a protein that is encoded by the HCRTR1 gene. The orexin 1 receptor (OX1) is a G-protein coupled receptor that is highly expressed in projections from the lateral hypothalamus and is involved in the regulation of feeding behavior.
OX1 selectively binds the orexin-A neuropeptide.
Complete Report Available at www.themarketreports.com/report/or…e-review-h2-2017
It also reviews key players involved in Orexin Receptor Type 1 targeted therapeutics development with respective active and dormant or discontinued projects.
Currently, The molecules developed by companies in Phase III, Phase II, Phase I, Preclinical and Discovery stages are 1, 1, 2, 7 and 3 respectively. Report covers products from therapy areas Central Nervous System which include indications Insomnia, Nicotine Addiction, Alcohol Addiction, Anxiety Disorders, Binge Eating Disorder, Drug Addiction, Addiction, Narcolepsy, Panic Disorders, Pathological Gambling and Sleep Disorders.
Access this Report at https://www.themarketreports.com/report/941421
Reasons To Access
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand the targeted therapy areas and indications for Orexin Receptor Type 1
- Identify the use of drugs for target identification and drug repurposing
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Orexin Receptor Type 1 development landscape
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Inquire About this Report at www.themarketreports.com/report/ask-your-query/941421
Category: Market Research Publishers and RetailersCompany about: The Market Reports aims to provide the best industry and market reports to a seeker. We are looking forward to a place where we are the one stop destination for all the report seekers irrespective of any country, category, domain, etc. We are always open on call and email (24*7) to your queries and very clean with the business methodology. Since we are dealing with so many Publishers, we can actually give you what suits best in accordance to your requirements.
For more information: